Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is U  [Clear All Filters]
Journal Article
Seki A, Sakai Y, Komura T, Nasti A, Yoshida K, Higashimoto M, Honda M, Usui S, Takamura M, Takamura T, et al. Adipose tissue-derived stem cells as a regenerative therapy for a murine steatohepatitis-induced cirrhosis model. Hepatology. 2013.
Uchimura R, Ueda T, Fukazawa R, Hayakawa J, Ohashi R, Miura NNagi, Ohno N, Migita M, Itoh Y. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatr Int. 2019.
Uchimura R, Ueda T, Fukazawa R, Hayakawa J, Ohashi R, Miura NNagi, Ohno N, Migita M, Itoh Y. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatr Int. 2019.
Yoshida Y, Matsubara H, Fang X, Hayashi K, Nomura I, Ugaji S, Hamada T, Tsuchiya H. Adipose-derived stem cell sheets accelerate bone healing in rat femoral defects. PLoS One. 2019;14(3):e0214488.
Shimizu M, Matsumine H, Osaki H, Ueta Y, Tsunoda S, Kamei W, Hashimoto K, Niimi Y, Watanabe Y, Miyata M, et al. Adipose-derived stem cells and the stromal vascular fraction in polyglycolic-acid (PGA)-collagen nerve conduits promote rat facial nerve regeneration. Wound Repair Regen. 2018.
Lynn JV, Lalchandani KB, Daniel M, Urlaub KM, Ettinger RE, Nelson NS, Donneys A, Buchman SR. Adipose-Derived Stem Cells Enhance Graft Incorporation and Mineralization in a Murine Model of Irradiated Mandibular Nonvascularized Bone Grafting. Ann Plast Surg. 2023;91(1):154-158.
Kido T, Miyagawa S, Goto T, Tamai K, Ueno T, Toda K, Kuratani T, Sawa Y. The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster. PLoS One. 2018;13(12):e0202838.
Ohira M, Kobayashi T, Tanaka Y, Imaoka Y, Sato K, Imaoka K, Nakano R, Doskali M, Piao J, Nakamura M, et al. Adoptive immunotherapy with natural killer cells from peripheral blood CD34 stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study. BMJ Open. 2022;12(11):e064526.
Gabarró-Solanas R, Davaatseren A, Kleifeld J, Kepčija T, Köcher T, Giralt A, Crespo-Enríquez I, Urbán N. Adult neural stem cells and neurogenesis are resilient to intermittent fasting. EMBO Rep. 2023:e57268.
Ghorbani S, Eyni H, Norahan MHadi, Zarrintaj P, Urban N, Mohammadzadeh A, Mostafavi E, Sutherland DS. Advanced bioengineering of female germ cells to preserve fertility. Biol Reprod. 2022.
Ullah R, Lee EJeong. Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases. Exp Neurobiol. 2023;32(4):216-246.
Masuku NPrenate, Unuofin JOshiomame, Lebelo SLucky. Advances in Nanoparticle Delivery System for Erectile Dysfunction: An Updated Review. Sex Med. 2021;9(5):100420.
Rajput S, Malviya R, Uniyal P. Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells. Curr Pharm Des. 2024.
Okada Y, Kimura F, Kurita N, Takahashi H, Shimazu Y, Mizuno S, Uchida N, Kataoka K, Hiramoto N, Ota S, et al. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma. Cytotherapy. 2023.
Isbell LK, Uibeleisen R, Friedl A, Burger E, Dopatka T, Scherer F, Orban A, Lauer E, Malenica N, Semenova I, et al. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial. BMC Cancer. 2023;23(1):767.
Toraño EG, Bayón GF, Del Real Á, Sierra MI, García MG, Carella A, Belmonte T, Urdinguio RG, Cubillo I, Garcia-Castro J, et al. Age-associated hydroxymethylation in human bone-marrow mesenchymal stem cells. J Transl Med. 2016;14(1):207.
Gullotta GSerena, De Feo D, Friebel E, Semerano A, Scotti GMaria, Bergamaschi A, Butti E, Brambilla E, Genchi A, Capotondo A, et al. Age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology. Nat Immunol. 2023.
Graffmann N, Brands J, Görgens A, Castro SVitoriano, Santourlidis S, Reckert A, Michele I, Ritz-Timme S, Fischer JChristian, Adjaye J, et al. Age-related increase of EED expression in early hematopoietic progenitor cells is associated with global increase of the histone modification H3K27me3. Stem Cells Dev. 2015.
Boffa G, Lapucci C, Sbragia E, Varaldo R, Raiola AM, Currò D, Roccatagliata L, Capello E, Laroni A, Mikulska M, et al. Aggressive multiple sclerosis: a single center, real-world treatment experience: aematopoietic stem cell transplantation and alemtuzumab. Eur J Neurol. 2020.
Imataki O, Uemura M. Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation. Clin Case Rep. 2024;12(1):e8415.
Odabas GPelin, Aslan K, Suna PAlisan, Kendirli PKader, Erdem S, Cakir M, Ozcan A, Yilmaz E, Karakukcu M, Donmez-Altuntas H, et al. Alantolactone ameliorates graft versus host disease in mice. Int Immunopharmacol. 2024;128:111560.
Ueda K, Ogasawara S, Akiba J, Nakayama M, Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K, et al. Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line. PLoS One. 2013;8(10):e75463.
Ueda K, Ogasawara S, Akiba J, Nakayama M, Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K, et al. Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line. PLoS One. 2013;8(10):e75463.
Furstenau D, Peer CJ, Hughes TE, Uchida N, Tisdale J, O Hall M, Figg WD, Hsieh M. Alemtuzumab Clearance, Lymphocyte Count, and T-Cell Chimerism After Hematopoietic Stem Cell Transplant in Sickle Cell Disease. Pharmacotherapy. 2021.
Hayward B, Kumari D, van Karnebeek CDM, van Kuilenburg ABP, Usdin K. All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency. bioRxiv. 2024.

Pages